Osteogenic action of anti-diabetic drug metformin in periodontal disease
- PMID: 24302843
- PMCID: PMC3831748
- DOI: 10.4103/0975-7406.120070
Osteogenic action of anti-diabetic drug metformin in periodontal disease
References
-
- Cortizo AM, Sedlinsky C, McCarthy AD, Blanco A, Schurman L. Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. Eur J Pharmacol. 2006;536:38–46. - PubMed
-
- Pradeep AR, Rao NS, Naik SB, Kumari M. Efficacy of varying concentrations of subgingivally delivered metformin in the treatment of chronic periodontitis: A randomized controlled clinical trial. J Periodontol. 2013;84:212–20. - PubMed
-
- Bak EJ, Park HG, Kim M, Kim SW, Kim S, Choi SH, et al. The effect of metformin on alveolar bone in ligature-induced periodontitis in rats: A pilot study. J Periodontol. 2010;81:412–9. - PubMed
-
- Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Sugimoto T. Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression. Biochem Biophys Res Commun. 2008;375:414–9. - PubMed
-
- Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, et al. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem. 2011;112:2902–9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources